Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

The interaction between gut microbiome and bone health
Francesco Inchingolo, Angelo Michele Inchingolo, Fabio Piras, et al.
Current Opinion in Endocrinology Diabetes and Obesity (2024) Vol. 31, Iss. 3, pp. 122-130
Open Access | Times Cited: 14
New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Suman Florentin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6218-6218
Open Access | Times Cited: 9
Gut microbiota interventions in type 2 diabetes mellitus: An umbrella review of glycemic indices
Mohammad‐Hossein Keivanlou, Ehsan Amini‐Salehi, Nazila Sattari, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103110-103110
Closed Access | Times Cited: 7
Targeting Gut microbiota as a therapeutic target in T2DM: a review of Multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the Intestinal Barrier
Keyu Chen, Han Wang, Xiaofei Yang, et al.
Pharmacological Research (2024) Vol. 210, pp. 107483-107483
Open Access | Times Cited: 7
Plant-Based Diets and Diabetes Risk: Which Foods, What Mechanisms?
Dariush Mozaffarian
Diabetes Care (2024) Vol. 47, Iss. 5, pp. 787-789
Open Access | Times Cited: 5
Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers: An umbrella review of meta-analyses
Yu Qing Jolene Teo, Bryan Chong, Rou Yi Soong, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1563-1583
Closed Access | Times Cited: 5
Comparative analysis of pectin and prebiotics on human microbiota modulation in early life stages and adults
Janaina Lombello Santos Donadio, João Paulo Fabi
Food & Function (2024) Vol. 15, Iss. 13, pp. 6825-6846
Closed Access | Times Cited: 5
Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review
Samradhi Singh, Mona Kriti, Anamika K.S., et al.
Metabolism Open (2024) Vol. 22, pp. 100287-100287
Open Access | Times Cited: 4
The impact of gut microbiome on immune and metabolic homeostasis in type 1 diabetes: Clinical insights for prevention and treatment strategies
Jiaqi Li, Zhiguo Xie, Lin Yang, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103371-103371
Closed Access
The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022
Aparajita Sarkar, Anfal Sher Khan, Ridhima Kaul, et al.
(2024)
Open Access | Times Cited: 3
Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies
Wen-Wen Liu, Lei Wang, Jinmei Ou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3752-3752
Open Access
Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence
Emily P. Van Syoc, Janhavi Damani, Zachary DiMattia, et al.
Advances in Nutrition (2023) Vol. 15, Iss. 1, pp. 100137-100137
Open Access | Times Cited: 9
PRO-DEMET Randomized Controlled Trial on Probiotics in Depression—Pilot Study Results
Oliwia Gawlik-Kotelnicka, Aleksandra Margulska, Anna Skowrońska, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1400-1400
Open Access | Times Cited: 7
The link between gut microbiome, nutraceuticals, diet, and diabetes mellitus: a bibliometric and visual analysis of research and emerging trends from 2012 to 2022
Aparajita Sarkar, Anfal Sher Khan, Ridhima Kaul, et al.
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Impact of live microbe intake on cardiovascular disease and mortality in adults with diabetes: A nationwide cohort study
Jiaqi Li, Jianan Ye, Qin Zhou, et al.
Diabetes Research and Clinical Practice (2024) Vol. 219, pp. 111942-111942
Closed Access | Times Cited: 2
Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials
Yousef Al‐Najjar, Maryam Arabi, Pradipta Paul, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 9
Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes
Zhihui Song, Yan An, Zehui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 5
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 4
The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103118-103118
Open Access | Times Cited: 1
Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial
Xuchao Peng, Xian Hong, Ning Ge, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications
Enriqueta García-Gutiérrez, A. Kate O’Mahony, Reinaldo S. Dos Santos, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Protein Extract of a Probiotic Strain of Hafnia alvei and Bacterial ClpB Protein Improve Glucose Tolerance in Mice
В. А. Золотарев, В. О. Муровец, A. L. Sepp, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10590-10590
Open Access | Times Cited: 3
Effects of probiotics, prebiotics and synbiotics supplementation on cardiovascular risk factors in patients with type 2 diabetes mellitus: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Yanyan Tian, Jiayue Xia, Lihua Li, et al.
Deleted Journal (2024)
Open Access
Functional foods for treating patients with diabetes: An overview of previous systematic reviews and meta-analyses and future prospects
Hidetaka Hamasaki
Elsevier eBooks (2024), pp. 43-76
Closed Access
Page 1 - Next Page

Scroll to top